Publicaciones en las que colabora con MARÍA ÁNGELES VILLANÚA BERNUÉS (20)

2006

  1. Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression

    Journal of Endocrinology, Vol. 188, Núm. 3, pp. 503-511

  2. Nitric oxide production by hepatocytes contributes to the inhibitory effect of endotoxin on insulin-like growth factor I gene expression

    Journal of Endocrinology, Vol. 190, Núm. 3, pp. 847-856

  3. Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritis rats

    Journal of Endocrinology, Vol. 191, Núm. 1, pp. 319-326

2005

  1. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 288, Núm. 3 51-3

  2. Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats

    Journal of Endocrinology, Vol. 185, Núm. 3, pp. 467-476

  3. Endotoxin administration increases hypothalamic somatostatin mRNA through nitric oxide release

    Regulatory Peptides, Vol. 124, Núm. 1-3, pp. 113-118

  4. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 289, Núm. 6

2004

  1. NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 286, Núm. 1 49-1

  2. Papel del óxido nítrico en la respuesta del IGF-I hepático a la inflamación

    Mapfre Medicina, Vol. 15, Núm. 1, pp. 20-27

2003

  1. Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats

    European Journal of Pharmacology, Vol. 481, Núm. 2-3, pp. 293-299

  2. Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats

    Journal of Endocrinology, Vol. 179, Núm. 1, pp. 107-117

  3. Endotoxin decreases serum IGFBP-3 and liver IGFBP-3 mRNA: Comparison between Lewis and Wistar rats

    Molecular and Cellular Endocrinology, Vol. 199, Núm. 1-2, pp. 23-28

  4. The inhibition of inducible nitric oxide synthase reverts arthritic-induced decrease in pituitary growth hormone mRNA but not in liver insulin-like growth factor I mRNA expression

    Journal of Neuroendocrinology, Vol. 15, Núm. 12, pp. 1178-1184

2002

  1. Arthritis-induced increase in serum levels of IGF-binding protein-3 in rats is secondary to the decrease in its proteolytic activity

    Journal of Endocrinology, Vol. 173, Núm. 2, pp. 357-364

  2. GH administration and renal IGF-I system in arthritic rats

    Life Sciences, Vol. 71, Núm. 2, pp. 139-151

  3. Glucocorticoids are not necessary for the inhibitory effect of endotoxic shock on serum IGF-I and hepatic IGF-I mRNA

    Journal of Endocrinology, Vol. 172, Núm. 3, pp. 449-456

  4. Hepatic insulin-like growth factor-I binding protein 3 gene expression in rats with endotoxic shock: The role of glucocorticoids

    Annals of the New York Academy of Sciences

  5. Papel del IGF-I y de la IGBP-3 en la regeneración tras la hepatectomía, efecto de la isquemia-reperfusión previa a la hepatectomía

    Mapfre Medicina

2001

  1. Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3

    British Journal of Sports Medicine, Vol. 35, Núm. 5, pp. 303-307

  2. The decrease in hepatic IGF-I gene expression in arthritis rats is not associated with modifications in hepatic GH receptor mRNA

    European Journal of Endocrinology, Vol. 144, Núm. 5, pp. 529-534